The mTORC1 Inhibitor Everolimus Combined with R-CHOP-21 for New Untreated Diffuse Large B-Cell Lymphoma (DLBCL): Safety and Efficacy Results of a Phase I and Feasibility Trial NCCTG 1085 (Alliance)
- Citation:
- Lancet Haematol vol 3 (7) e309-e316
- Year:
- 2016
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pmc-release
- Note:
- Pharmas:
- Grants:
- R01 CA127433, U10 CA180821, U10 CA180790, U10 CA180882, P50 CA097274, U10 CA180867, U10 CA025224
- Corr. Author:
- Patrick B. Johnston
- Authors:
- Patrick B. Johnston Betsy LaPlant Ellen McPhail Thomas M. Habermann David J. Inwards Ivana N. Micallef Joseph P. Colgan Grzegorz S. Nowakowski Stephen M. Ansell Thomas E. Witzig
- Networks:
- LAPS-MN026
- Study
- NCCTG-N1085
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 1
- Keywords:
- Everolimus, mTORC1, DLBCL